Clinical Trial

Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES)

Study acronym: GENCOMX
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
In this study, the investigators evaluated the effectiveness and safety of using the GENOSS® DES, which has a biodegradable polymer only on the inner wall of the blood vessel, for patients(all-comers) with coronary artery disease who require percutaneous coronary intervention through stent insertion.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-10-16.
Status change: Recruiting → Enrolling by Invitation 2025-09-30
Trial Details
NCT Number NCT06086496
Lead Sponsor Genoss Co., Ltd.
Conditions Coronary Artery Disease, Percutaneous Coronary Intervention
Enrollment 1,000 participants
Start Date 2022-07-15
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-06